Key facts
- SentiAR’s last known valuation is $31.0M (Apr 2023).
- It has raised $18.6M across 6 recorded rounds; the latest was Seed Round ($1.5M) in Apr 2026.
- Notable investors include Service Provider Capital, Keiretsu Forum, Cultivation Capital, BioGenerator Ventures, Arch Grants — 20 tracked in total.
- SentiAR has filed 6 Form Ds with the SEC since 2017, most recently May 2025 ($2.5M sold to 20 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for SentiAR
Funding rounds
6 roundsAbout SentiAR
Developer of augmented reality visualization technology designed for interventional cardiac procedures such as ablation. The company's platform features real-time holographic visualization of the patient's anatomy using real-time data from catheters and 3D electroanatomic mapping systems, enabling clinicians, radiologists, neurologists, and anesthetists to treat arrhythmia patients.
- Sector
- Healthcare
- HQ
- Saint Louis, MO, United States
- Founded
- 2017
- Employees
- 16
- Website
- sentiar.com/
- Ownership
- Privately Held (backing)
SentiAR doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SentiAR shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SentiAR in its N-PORT filings yet. We sweep new filings monthly.